Genomics

Dataset Information

0

Endocrine treatment potentiates antigen presentation and in combination with SMAC mimetics enhances an anti-tumor immune response in hormone receptor positive breast cancer (RNA-rela-KOs)

ABSTRACT: To investigate the effects of endocrine treatment in combination with SMAC mimetics in ER+ breast cancer on tumor cell response to IFNg

ORGANISM(S): Homo sapiens

PROVIDER: GSE214052 | GEO | 2023/07/08

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown Endocrine treatment potentiates antigen presentation and in combination with SMAC mimetics enhances an anti-tumor immune response in hormone receptor positive breast cancer (RELA ChIP)
2023-07-08 | GSE214044 | GEO
Unknown Endocrine treatment potentiates antigen presentation and in combination with SMAC mimetics enhances an anti-tumor immune response in hormone receptor positive breast cancer (orig)
2023-07-08 | GSE213481 | GEO
Unknown Endocrine treatment potentiates antigen presentation and in combination with SMAC mimetics enhances an anti-tumor immune response in hormone receptor positive breast cancer (RNA-seq)
2023-07-08 | GSE213474 | GEO
Unknown Endocrine treatment potentiates antigen presentation and in combination with SMAC mimetics enhances an anti-tumor immune response in hormone receptor positive breast cancer (RNA-seq WT_Talen)
2023-07-08 | GSE213477 | GEO
Unknown Endocrine treatment potentiates antigen presentation and in combination with SMAC mimetics enhances an anti-tumor immune response in hormone receptor positive breast cancer (ATAC-seq WH/E2)
2023-07-08 | GSE213484 | GEO
Transcriptomics Expression data from MDA-MB-231 parental and xenograft tumor cells treated with Smac mimetic SM-164.
2012-03-01 | E-GEOD-33827 | biostudies-arrayexpress
Unknown Expression data from MDA-MB-231 parental and xenograft tumor cells treated with Smac mimetic SM-164.
2012-03-01 | GSE33827 | GEO
Unknown Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells
2017-01-26 | GSE86839 | GEO
Unknown Biomarker Profile for Prediction of Response to SMAC Mimetic Monotherapy in Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia
2021-11-18 | GSE140556 | GEO
Unknown Endocrine treatment potentiates antigen presentation and in combination with SMAC mimetics enhances an anti-tumor immune response in hormone receptor positive breast cancer
2023-07-08 | GSE214054 | GEO